Publications
Included here is a list of publications from OCG programs. All published data are available to the research community through the program-specific data matrices.
* denotes publications from the CTD2 initiative that are results of intra-Network collaborations
CGCI
Nature genetics
HTMCP scientists reveal the influence of HPV clades on molecular characteristics of HIV+ and HIV- cervical tumors from Ugandan patients. The study provides insights into the role of HIV infection, and how different HPV clades lead to specific molecular changes that could affect patient prognosis.
CTD²
J Mol Cell Biol.
CTD²
Nat Protoc.
CTD²
Nucleic Acids Res.
CTD²
Nature Communications
CTD²
Mol Syst Biol.
CTD²
Blood
Study highlights the usage of FDA-approved tyrosine kinase inhibitors for treating leukemia patients with neurotrophic receptor tyrosine kinase mutations.